A phase 2 study of magrolimab combination therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma: ELEVATE HNSCC Colevas, A., Dinis, J., Chin, V. T., Costa, D., Park, J. J., Fang, B., Phan, M., Zhang, Y., U'Ren, L., Odegard, J., Curtis, K., Pirtle, E., Adkins, D. LIPPINCOTT WILLIAMS & WILKINS. 2023

View details for Web of Science ID 001053772005408